As presented in Table 1, patients in the high FAR cohort were older, had higher serum levels (platelet, neutrophil, lymphocyte counts, etc.), lower serum albumin levels, worse liver background (higher frequency of Child–Pugh grade B, cirrhosis and CSPH), worse tumor condition (larger tumor size, multiple tumors, with macrovascular invasion (MVI) and advanced BCLC staging), and worse surgical environment (greater blood loss and transfusions, more major resections). The gene discussed is ALB; the disease is neoplasm.